[1] |
TRAPNELL B C, NAKATA K, BONELLA F,et al. Pulmonary alveolar proteinosis[J]. Nat Rev Dis Primers, 2019, 5(1):16. DOI: 10.1038/s41572-019-0066-3.
|
[2] |
JOUNEAU S, MÉNARD C, LEDERLIN M. Pulmonary alveolar proteinosis[J]. Respirology, 2020, 25(8):816-826. DOI: 10.1111/resp.13831.
|
[3] |
KUMAR A, ABDELMALAK B, INOUE Y,et al. Pulmonary alveolar proteinosis in adults:pathophysiology and clinical approach[J]. Lancet Respir Med,2018,6(7):554-565.
|
[4] |
INOUE Y, TRAPNELL B C, TAZAWA R,et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan[J]. Am J Respir Crit Care Med, 2008, 177(7):752-762. DOI: 10.1164/rccm.200708-1271OC.
|
[5] |
AKASAKA K, TANAKA T, KITAMURA N,et al. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis:a retrospective cohort study[J]. BMC Pulm Med, 2015, 15:88. DOI: 10.1186/s12890-015-0085-0.
|
[6] |
SEYMOUR J F, PRESNEILL J J. Pulmonary alveolar proteinosis:progress in the first 44 years[J]. Am J Respir Crit Care Med, 2002, 166(2):215-235. DOI: 10.1164/rccm.2109105.
|
[7] |
SHAH P L, HANSELL D, LAWSON P R,et al. Pulmonary alveolar proteinosis:clinical aspects and current concepts on pathogenesis[J]. Thorax,2000,55(1):67-77.
|
[8] |
UCHIDA K, NAKATA K, CAREY B,et al. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis[J]. J Immunol Methods,2014,402(1/2):57-70.
|
[9] |
BORIE R, DANEL C, DEBRAY M P,et al. Pulmonary alveolar proteinosis[J]. Eur Respir Rev,2011,20(120):98-107.
|
[10] |
JOUNEAU S, KERJOUAN M, BRIENS E,et al. Laprotéinosealvéolaire pulmonaire[J]. Revue Des Maladies Respir,2014,31(10):975-991.
|
[11] |
BEN-DOV I, SEGEL M J. Autoimmune pulmonary alveolar proteinosis:clinical course and diagnostic criteria[J]. Auto immun Rev,2014,13(4/5):513-517.
|
[12] |
CAMPO I, LUISETTI M, GRIESE M,et al. A global survey on whole lung lavage in pulmonary alveolar proteinosis[J]. Chest, 2016, 150(1):251-253. DOI: 10.1016/j.chest.2016.04.030.
|
[13] |
SHENG G H, CHEN P, WEI Y Q,et al. Better approach for autoimmune pulmonary alveolar proteinosis treatment:inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor:a meta-analyses[J]. Respir Res,2018,19(1):163.
|
[14] |
TAZAWA R, TRAPNELL B C, INOUE Y,et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis[J]. Am J Respir Crit Care Med,2010,181(12):1345-1354.
|